David B. Pittrow

Chemnitzer Str. 46
Dresden, SN 01187, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 126 publications

Association Between Invasive Cardiac Hemodynamics and Kidney Function in Patients with Pulmonary Hypertension.

Association Between Invasive Cardiac Hemodynamics and Kidney Function in Patients with Pulmonary Hypertension.

Journal: Kidney360

Published: January 07, 2026

Sex-Specific Phenotypes and Outcomes in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease: Results from the INSIGHTS-ILD Registry.

Sex-Specific Phenotypes and Outcomes in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease: Results from the INSIGHTS-ILD Registry.

Journal: Respiration; international review of thoracic diseases

Published: December 31, 2025

Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA).

Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA).

Journal: Rheumatology and therapy

Published: October 09, 2025

Treatment Algorithm of Pulmonary Arterial Hypertension

Treatment Algorithm of Pulmonary Arterial Hypertension

Journal: Pneumologie (Stuttgart, Germany)

Published: October 06, 2025

Risk Stratification and Treatment Goals for Pulmonary Arterial Hypertension

Risk Stratification and Treatment Goals for Pulmonary Arterial Hypertension

Journal: Pneumologie (Stuttgart, Germany)

Published: October 06, 2025

Sex differences in IPF: data from the German INSIGHTS-registry.

Sex differences in IPF: data from the German INSIGHTS-registry.

Journal: Respiration; international review of thoracic diseases

Published: September 13, 2025

Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registry.

Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registry.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: August 31, 2025

Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis.

Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis.

Journal: American journal of respiratory and critical care medicine

Published: August 07, 2025

Pain and Health Related Quality of Life in Patients with Superficial Vein Thrombosis: A Post Hoc Analysis of the Multicentre INSIGHTS-SVT Study.

Pain and Health Related Quality of Life in Patients with Superficial Vein Thrombosis: A Post Hoc Analysis of the Multicentre INSIGHTS-SVT Study.

Journal: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery

Published: May 27, 2025

Risk stratification as a guide to goal-oriented management of patients with fibrotic interstitial lung disease: a registry-based analysis.

Risk stratification as a guide to goal-oriented management of patients with fibrotic interstitial lung disease: a registry-based analysis.

Journal: ERJ open research

Published: April 25, 2025

Determinants of lipid lowering therapy intensification in very high risk patients with dyslipidaemia eligible for PCSK9 monoclonal antibodies: 1-year outcomes of the PERI-DYS study.

Determinants of lipid lowering therapy intensification in very high risk patients with dyslipidaemia eligible for PCSK9 monoclonal antibodies: 1-year outcomes of the PERI-DYS study.

Journal: Acta cardiologica

Published: April 24, 2025

Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodies.

Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodies.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: April 08, 2025

Showing 1-12 of 126

Last Updated: 09/26/2026